1st Circ. Won't Rethink Revival Of PharMerica FCA Suit
The First Circuit on Monday rejected PharMerica Corp.'s request to rethink a panel decision reviving a whistleblower's False Claims Act suit accusing the company of overbilling Medicare and Medicaid by asking...To view the full article, register now.
Already a subscriber? Click here to view full article